. . . . . . . . . . . . . . . . . . "kin(p(HGNC:PRKD3)) -> kin(p(HGNC:MAPK3))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "we examined the requirement for PKCs in the PMA-induced activation of ERKs by using different PKC inhibitors. Treatment with GF109203X resulted in a total inhibition of ERKs activation, whereas rottlerin had no effect (Figure 8). Because rottlerin is unable to block the activation of ERKs by PMA, PKC-d is not implicated in this process. Given that atypical PKCs were not activated by PMA on the XG-6 cells, these results suggest that PKC-z was not involved...Finally, because XG-6 cells express PKC-nu and PKC-d as novel PKC isoforms, we can assume that the novel PKC, namely PCK-nu, is involved in the activation of ERKs by PMA." . . "Selventa" . . . . "2014-07-03T14:29:57.724+02:00"^^ . . .